Pioneering work to develop effective and safe bacteriophages to combat disease has received an £800,000 boost.
Fecal microbe transplants from healthy donors can treat patients with recurrent Clostridium difficile infections. However, after tens of thousands transplants, little was known about which
Factors that increase the risk of dementia have a greater impact on risk for people in minority ethnic groups, finds a new study led by
International law supports women’s right to breastfeed in the public. However, women report having been subjected to negative responses and judgmental looks when breastfeeding outside
Infertility now affects one in six couples of reproductive age according to the World Health Organisation. About half the time, it originates from men.
Worries that surgery patients would have a tougher recovery if their doctors had to abide by a five-day limit on opioid pain medication prescriptions didn’t
This past quarter has been, without a doubt, the busiest and most transformative three months of this year— perhaps even of the entire history of
Cybin Inc. (NYSE AMERICAN:CYBN) (NEO:CYBN) (“Cybin” or the “Company”), a clinical-stage biopharmaceutical company committed to revolutionizing mental healthcare by developing new and innovative psychedelic-based treatment options,
-Shareholders overwhelmingly vote in favour of Cybin’s acquisition of Small Pharma Small Pharma Inc. (TSXV: DMT) (OTCQB: DMTTF) (the “Company” or “Small Pharma”), a biotechnology
Optimind Pharma Corp. (CSE: OMND) (the “Optimind” or the “Company”) is pleased to announce that it has entered into an acquisition agreement dated October 12,